MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

Search

Stevanato Group SpA

Fechado

SetorSaúde

13.74 0.59

Visão Geral

Variação de preço das ações

24h

Atual

Mín

13.38

Máximo

13.81

Indicadores-chave

By Trading Economics

Rendimento

-2M

47M

Vendas

40M

343M

P/E

Médio do Setor

22.831

56.063

Margem de lucro

13.738

Funcionários

6,010

EBITDA

18M

90M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+78.44% upside

Dividendos

By Dow Jones

Próximos Ganhos

7 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-442M

3.7B

Abertura anterior

13.15

Fecho anterior

13.74

Sentimento de Notícias

By Acuity

50%

50%

170 / 349 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Weak Bullish Evidence

Stevanato Group SpA Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

6 de abr. de 2026, 23:17 UTC

Ganhos

Samsung Forecasts Record First-Quarter Operating Profit

6 de abr. de 2026, 23:00 UTC

Ações em Alta

Stocks to Watch: Health Insurers, Mawson, Owlet

6 de abr. de 2026, 22:13 UTC

Grandes Movimentos do Mercado

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6 de abr. de 2026, 21:46 UTC

Aquisições, Fusões, Aquisições de Empresas

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6 de abr. de 2026, 17:09 UTC

Grandes Movimentos do Mercado

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6 de abr. de 2026, 16:56 UTC

Notícias Principais

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6 de abr. de 2026, 14:47 UTC

Grandes Movimentos do Mercado

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7 de abr. de 2026, 00:00 UTC

Notícias Principais

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6 de abr. de 2026, 23:58 UTC

Conversa de Mercado
Notícias Principais

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6 de abr. de 2026, 23:50 UTC

Conversa de Mercado

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6 de abr. de 2026, 23:36 UTC

Conversa de Mercado

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6 de abr. de 2026, 23:15 UTC

Conversa de Mercado

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6 de abr. de 2026, 22:52 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

6 de abr. de 2026, 22:52 UTC

Conversa de Mercado

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6 de abr. de 2026, 22:14 UTC

Conversa de Mercado

Correction to Live Cattle Futures Article

6 de abr. de 2026, 20:56 UTC

Conversa de Mercado

Mexican Private Consumption Fell in January -- Market Talk

6 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Energy & Utilities Roundup: Market Talk

6 de abr. de 2026, 20:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

6 de abr. de 2026, 19:58 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

6 de abr. de 2026, 19:58 UTC

Conversa de Mercado

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6 de abr. de 2026, 19:11 UTC

Conversa de Mercado

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6 de abr. de 2026, 19:06 UTC

Conversa de Mercado

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6 de abr. de 2026, 19:03 UTC

Conversa de Mercado

Global Energy Roundup: Market Talk

6 de abr. de 2026, 19:03 UTC

Conversa de Mercado

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6 de abr. de 2026, 18:36 UTC

Aquisições, Fusões, Aquisições de Empresas

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 de abr. de 2026, 17:59 UTC

Conversa de Mercado
Notícias Principais

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6 de abr. de 2026, 17:13 UTC

Aquisições, Fusões, Aquisições de Empresas

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 de abr. de 2026, 16:33 UTC

Conversa de Mercado

Oil Futures Steady as Market Awaits Trump -- Market Talk

6 de abr. de 2026, 16:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

6 de abr. de 2026, 14:59 UTC

Ganhos

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Comparação entre Pares

Variação de preço

Stevanato Group SpA Previsão

Preço-alvo

By TipRanks

78.44% parte superior

Previsão para 12 meses

Média 24.5 USD  78.44%

Máximo 32 USD

Mínimo 17.5 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Stevanato Group SpA - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

6 ratings

4

Comprar

2

Manter

0

Vender

Pontuação Técnica

By Trading Central

21.56 / 22.61Suporte e Resistência

Curto Prazo

Weak Bullish Evidence

Médio Prazo

Weak Bearish Evidence

Longo Prazo

Bullish Evidence

Sentimento

By Acuity

170 / 349 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Stevanato Group SpA

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
help-icon Live chat